| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/11/1999 | EP0934999A1 DNA mutagenesis by random fragmentation and reassembly |
| 08/11/1999 | EP0934952A2 Peptides containing an N-substituted glycine residue |
| 08/11/1999 | EP0934950A1 Tetrapeptide derivative |
| 08/11/1999 | EP0934748A2 Von Willenbrand factor (vWF)- containing preparation, process for preparing vWF-containing preparations, and use of such preparations |
| 08/11/1999 | EP0934427A1 Rh blood group antigen compositions and methods of use |
| 08/11/1999 | EP0934424A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 08/11/1999 | EP0934422A2 Gene therapy for congestive heart failure |
| 08/11/1999 | EP0934414A1 Interferon related protein hkafe42 |
| 08/11/1999 | EP0934413A1 Placental-derived prostate growth factors |
| 08/11/1999 | EP0934412A1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF |
| 08/11/1999 | EP0934411A1 Compositions for treating anemia |
| 08/11/1999 | EP0934410A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 08/11/1999 | EP0934409A2 Diabetes-mediating proteins and therapeutic uses thereof |
| 08/11/1999 | EP0934408A1 Nucleic acid encoding ds-cam proteins and products related thereto |
| 08/11/1999 | EP0934405A1 Melanoma associated peptide analogues and vaccines against melanoma |
| 08/11/1999 | EP0934404A1 Inhibition of proliferation of cells |
| 08/11/1999 | EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 08/11/1999 | EP0934340A1 Novel compounds |
| 08/11/1999 | EP0934339A1 IgG IMMUNOGLOBULINS AND F(ab') 2? FRAGMENTS THEREOF, SPECIFIC FOR DRUGS AND METABOLITES THEREOF, AND THEIR USE FOR DETOXIFICATION PURPOSES |
| 08/11/1999 | EP0934337A1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma |
| 08/11/1999 | EP0934336A1 Novel compounds |
| 08/11/1999 | EP0934335A1 Novel compounds |
| 08/11/1999 | EP0934329A1 Glycoconjugates from modified camptothecin derivates (20-o-linkage) |
| 08/11/1999 | EP0934305A1 Integrin antagonists |
| 08/11/1999 | EP0934291A1 Protease inhibitors |
| 08/11/1999 | EP0934282A1 1,4-benzodiazepinones and their uses as cck antagonists |
| 08/11/1999 | EP0934270A1 A method of treating cancer |
| 08/11/1999 | EP0934081A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol |
| 08/11/1999 | EP0934076A1 Solid phase lipoglycopeptide library, compositions and methods |
| 08/11/1999 | EP0934075A2 Method for the prevention and treatment of mastitis |
| 08/11/1999 | EP0934073A1 Pharmaceutical composition, comprising complement proteins, for the treatment of helicobacter infections and a method for the preparation of the composition |
| 08/11/1999 | EP0934072A1 Manufacturing process for the production of purified transferrin |
| 08/11/1999 | EP0934064A1 Thrombin inhibitors |
| 08/11/1999 | EP0934063A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
| 08/11/1999 | EP0934059A1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
| 08/11/1999 | EP0933995A1 Method of treating endothelial injury |
| 08/11/1999 | EP0759032B1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
| 08/11/1999 | EP0756605B1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
| 08/11/1999 | EP0725651B1 Hemoregulatory peptides |
| 08/11/1999 | EP0719281B1 Multiple branch peptide constructions for use against hiv |
| 08/11/1999 | EP0701572B1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv |
| 08/11/1999 | EP0669937B1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 08/11/1999 | EP0646132B1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
| 08/11/1999 | EP0584185B1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 08/11/1999 | EP0584171B1 Composition and method of treating depigmentation disorders |
| 08/11/1999 | EP0580778B1 Convertible microemulsion formulations |
| 08/11/1999 | CN1225723A Immunological process for detecting antibadies directed towards tissue transglutaminase (TTG), use of TTG for diagnostic purposes and therapy control, and oral pharmaceutical agent therewith |
| 08/11/1999 | CN1225688A Novel antitumor compounds and process for producing same |
| 08/11/1999 | CN1225683A Vasoactive amine binding molecules |
| 08/11/1999 | CN1225682A Method and compositions for regulating T cell subsets by modulating transcription facter activity |
| 08/11/1999 | CN1225653A Antiviral linear polymer |
| 08/11/1999 | CN1225640A Hodgkin disease associated molecules and uses thereof |
| 08/11/1999 | CN1225590A Peptides with increased binding affinity for HLA molecules |
| 08/11/1999 | CN1225575A Method for althering hair growth and hair pigmentation and compositions therefor |
| 08/11/1999 | CN1225368A Interleukin -2/granulocyte-macrophage colony stimulating factor fusion protein |
| 08/11/1999 | CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease |
| 08/11/1999 | CN1225360A Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them |
| 08/11/1999 | CN1225276A Drug for radical curing dental caries |
| 08/10/1999 | US5936138 Gene encoding mutant L3T4 protein which facilitates HIV infection and transgenic mouse expressing such protein |
| 08/10/1999 | US5936092 Fatty acid conjugate containing a disulfide linkage; increased absorption of compounds |
| 08/10/1999 | US5936089 Dipeptides which promote release of growth hormone |
| 08/10/1999 | US5936079 Oligonucleotide which binds to a chromosomal binding site for p53 protein |
| 08/10/1999 | US5936078 DNA and protein for the diagnosis and treatment of Alzheimer's disease |
| 08/10/1999 | US5936074 Reacting teicoplanin with echinocandin beta deacylase, then forming salt and/or deprotecting amino group; bactericides against gram-positive bacteria |
| 08/10/1999 | US5936067 Macrophage inflammatory protein variants |
| 08/10/1999 | US5936066 Recombinant human interleukin-1α |
| 08/10/1999 | US5936065 CS-1 peptidomimetics, compositions and methods of using the same |
| 08/10/1999 | US5936064 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 08/10/1999 | US5936063 A korean toad, bufo bufo gargarizans, which shows stronger antibacterial and antifungal activities than any other conventional antimicrobial peptides. |
| 08/10/1999 | US5936062 Process for preparing certain aza cyclohexapeptides |
| 08/10/1999 | US5936035 Comprising fibrillar collagen, a fiber disassembly agent to make nonfibrillar collagen and an activated polymer, e.g. polyoxyethylene glycol to form a covalently bonded collagen-polymer conjugate; surgical adhesions; eye implants |
| 08/10/1999 | US5935988 Mixtures of 2-amino-4-methylenecyclopentanecarboxylic acid with isoleucine, alanine or proline |
| 08/10/1999 | US5935980 Use of pyrrolidine derivatives in the treatment of alcoholism |
| 08/10/1999 | US5935976 Viricides, hiv |
| 08/10/1999 | US5935954 Compounds with improved multi-drug resistance activity |
| 08/10/1999 | US5935940 Compositions and methods for modulating growth of a tissue in a mammal |
| 08/10/1999 | US5935937 Antisense oligonucleotide for inhibiting production of fusion protein in malignant cell |
| 08/10/1999 | US5935934 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 08/10/1999 | US5935932 Bradykinin antagonists containing pentafluorophenylalanine |
| 08/10/1999 | US5935931 Human apoptosis-related calcium-binding protein |
| 08/10/1999 | US5935930 Antithrombotic materials and methods |
| 08/10/1999 | US5935929 Methods for treating interstitial lung disease by using interleukin-9 and its antagonists |
| 08/10/1999 | US5935928 Modified platelet factor-4 |
| 08/10/1999 | US5935927 Alzheimer*s disease, diabetes; removal amyloid from brain, pancreas |
| 08/10/1999 | US5935926 Platelet aggregation inhibitors |
| 08/10/1999 | US5935925 Methods of treating migraine and compounds useful for such methods |
| 08/10/1999 | US5935924 Administering an effective dosage of growth hormone or a mixture ofgrowth hormone and angiotensin-converting enzyme inhibitor to mammals |
| 08/10/1999 | US5935865 Semaphorin gene family |
| 08/10/1999 | US5935860 Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia |
| 08/10/1999 | US5935856 It is known that bfgf is a heparin-binding, multifunctional protein that has until now been recognized primarily for its mitogenic and angiogenic properties. |
| 08/10/1999 | US5935854 Human amyloid protein precursor homolog and kunitz-type inhibitor |
| 08/10/1999 | US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo. |
| 08/10/1999 | US5935851 TPR-containing genes |
| 08/10/1999 | US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase. |
| 08/10/1999 | US5935830 Site-directed mutagenesis by forming triple helix with double-stranded dna and oligonucleotide with electrophilic group, electrophilic group causes modification of dna nucleotide, then replication causes mutation |
| 08/10/1999 | US5935820 Polynucleotides encoding vascular endothelial growth factor 2 |
| 08/10/1999 | US5935819 Process for producing a pharmaceutical preparation of PDGF-AB |
| 08/10/1999 | US5935817 Genetic engineering |
| 08/10/1999 | US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds |
| 08/10/1999 | US5935815 Culturing genetically engineered cells expressing both a proform of a protein and furin, isolating activated protein form |